A Smarter Integrative Approach to Hormone Balance Explained

A Smarter Integrative Approach to Hormone Balance

Abstract

Navigating the complex world of hormonal health requires a nuanced, evidence-based approach that considers each patient’s unique physiology. This educational post explores the intricate interplay among hormones such as testosterone, progesterone, and estrogen, drawing on the latest research and extensive clinical experience. We will delve into strategies for managing common yet challenging conditions, including iron deficiency anemia in women, Polycystic Ovary Syndrome (PCOS), and the side effects of hormone replacement therapy. I will discuss the physiological principles of hormone absorption, distribution, and excretion, explaining how factors such as body mass, cardiac output, and renal function influence treatment efficacy. Furthermore, we will examine the critical risk-benefit analysis of contraceptive methods in perimenopausal women, the management of high Sex Hormone-Binding Globulin (SHBG), and the true risks associated with hormone therapy. By integrating these principles with a holistic framework that includes chiropractic care, we can create personalized, effective treatment plans that restore balance, alleviate symptoms, and optimize long-term health.

As a practitioner dedicated to integrative medicine, I am constantly exploring the connections among the body’s systems. My work at our clinics has shown me time and again that a patient’s journey to wellness is rarely linear. It involves a deep dive into their unique biochemistry, lifestyle, and health history. Today, I want to share some insights and clinical pearls gleaned from my practice and the work of leading researchers in hormonal health. This is a field where a one-size-fits-all approach simply doesn’t work, and a personalized, integrative strategy is paramount.

Addressing Iron Deficiency and Hormonal Imbalance in Women

One of the most common issues I see in my female patients is iron deficiency, often leading to anemia. For many women, this is directly linked to heavy menstrual bleeding. The first step in management is to bring the right therapeutic tools into play. While it might seem counterintuitive, addressing copper levels can be crucial for improving iron status and resolving anemia.

When a patient presents with heavy bleeding, a common and effective strategy is to use cyclic progesterone. However, determining the right dosage and timing is key.

• For heavy bleeding: I often start with a protocol of 200 mg of progesterone nightly for a specific cycle, such as days 14 through 28. This helps stabilize the uterine lining.
• The risk of continuous high-dose progesterone: If you administer a high dose, such as 200 mg, every night without a break, the body’s natural feedback loops can become confused. The endocrine system loses its ability to regulate the menstrual cycle, which can lead to unpredictable breakthrough bleeding. The patient’s system essentially “breaks.”
• A more sustainable approach: A continuous dose of 100 mg nightly can be more manageable, though it’s important to recognize that even at this level, natural hormonal fluctuations will still occur.

After implementing a cyclic progesterone protocol for about three months and observing a normalization of the patient’s cycle, we can then begin to address other underlying issues. It’s also vital to integrate iron supplementation and ensure normal thyroid function, as both are fundamental pillars in resolving anemia and supporting overall metabolic health.

In my clinical experience, I’ve also found this approach beneficial for patients with Polycystic Ovary Syndrome (PCOS), a condition often characterized by hormonal dysregulation and metabolic issues. A significant percentage of these patients, perhaps as high as 60%, can benefit from carefully managed progesterone therapy.

Hormonal Health After Bariatric Surgery

We are seeing a growing population of younger patients who have undergone bariatric surgery, such as gastric bypass. These individuals often present with unique challenges related to nutrient absorption and hormonal balance. Previously, our primary focus in this area might have been on older populations or cancer survivors, but this new demographic requires a tailored approach.

My treatment philosophy for post-bariatric patients remains rooted in foundational functional medicine principles.

1. Gut Health is Paramount: Even though the anatomy of the gastrointestinal tract has been altered, the principles of gut health remain the same. Probiotics are essential. While some patients may have difficulty tolerating certain formulations due to changes in gastric acid, there are many specialized products designed for sensitive systems. The goal is to support a healthy microbiome, as much of the body’s immune and metabolic regulation happens in the gut.
2. Addressing Malabsorption: Post-bariatric surgery can significantly impair nutrient absorption, including from hormone therapies. If a patient is not responding as expected, it’s crucial to investigate malabsorption. We may need to consider alternative delivery methods for hormones and supplements to bypass the compromised upper gastrointestinal tract.
3. The Impact on Testosterone: A fascinating clinical observation in patients who have lost a significant amount of weight is the effect on their testosterone levels. One might expect testosterone to rise naturally as body fat decreases and insulin sensitivity improves. However, I have often seen a less significant increase than anticipated. For example, a patient who goes from 250 pounds to 190 pounds may not see the dramatic testosterone boost we would hope for. This leads us to a deeper physiological discussion about how hormones work in the body.

The Three Pillars of Hormone Pharmacokinetics: Absorption, Distribution, and Excretion

To understand why a patient responds a certain way to hormone therapy, we must understand its journey through the body. This journey can be broken down into three key stages: absorption, distribution, and excretion.

1. Absorption

When we use subcutaneous hormone pellets, for example, absorption depends primarily on two factors: surface area and cardiac output. The pellets are inserted under the skin, where they are surrounded by a vast network of capillaries.

• Surface Area: The physical size of the pellet implant determines the surface area available for hormone absorption into the bloodstream.
• Cardiac Output: This is where lifestyle plays a huge role. The more a person exercises, the higher their cardiac output. Increased blood flow past the pellets leads to faster and more efficient absorption. This is why active individuals often report feeling the positive effects of their therapy more quickly and maintain better levels.

2. Distribution

Once in the bloodstream, the hormone is distributed throughout the body. This process is largely governed by a person’s body mass index (BMI) and total body weight. The hormone spreads out across all tissues, including fat and muscle. If a patient loses a significant amount of weight—say, 20% of their body fat—there is less tissue for the hormone to distribute over. This means the same dose can result in a higher concentration in the target tissues, potentially leading to a more robust response even with a lower dose.

3. Excretion

Finally, hormones are metabolized and cleared from the body. Testosterone is specifically cleared almost 100% via renal excretion (by the kidneys).

• Age and Kidney Function: As we age, our kidney function naturally slows. This means older individuals clear hormones from their system more slowly.
• Clinical Application: This physiological reality has direct clinical implications. I often find that my older male patients, particularly those in their 80s, require much lower doses of testosterone, and the effects last significantly longer. It’s not uncommon for an 86-year-old man to have a single pellet insertion last for six, or even nine, months because his clearance rate is so slow. Understanding this principle of excretion is vital for safe and effective dosing, preventing the accumulation of hormones to unsafe levels.

Managing Estrogen-Related Side Effects in Men

A common concern among men starting testosterone replacement therapy (TRT) is the potential for estrogen-related side effects, such as breast tenderness or increased nipple sensitivity. These symptoms arise from the aromatization of testosterone into estrogen.

It’s important to reassure patients that this is typically a transient phenomenon. In my experience, these side effects almost exclusively occur during the very first treatment cycle, when the body is adjusting to a dramatic shift from very low to optimal testosterone levels. After this initial adaptation period, the body establishes a new equilibrium, and these symptoms rarely recur.

Occasionally, a patient who has been stable on therapy for a long time will come in complaining of these symptoms, often after hearing from someone at the gym that an “aromatase inhibitor” or an “estrogen blocker” will help them get “super jacked.” In these cases, it’s often a misinformed attempt to get a higher dose or an additional medication. I handle this by explaining the physiology: adding unnecessary medications can disrupt their hormonal balance, leading to undesirable side effects like erectile dysfunction, and will not provide the benefits they are seeking. Education and clear communication are our best tools.

The Critical Role of Integrative Chiropractic Care

This is where the principles of integrative chiropractic care become so valuable. As a Doctor of Chiropractic, I view the body as a self-regulating, interconnected system. The nervous system, which is the master controller of the body, is profoundly influenced by the endocrine system, and vice versa.

• Neuro-Endocrine Connection: Chiropractic adjustments help optimize nervous system function by correcting spinal misalignments (subluxations). A well-functioning nervous system ensures that the signals between the brain and the endocrine glands—such as the adrenal glands, thyroid, and gonads—are clear and balanced. This can help regulate the body’s natural stress response (cortisol production), which has a massive impact on sex hormones.
• Improving Circulation: Chiropractic care can also improve overall circulation and blood flow. As we discussed, cardiac output is critical for the absorption of hormone pellets. By improving biomechanics and reducing musculoskeletal tension, we support the cardiovascular system, indirectly enhancing the efficacy of hormone therapy.
• Holistic Patient Management: In our practice, we don’t just administer a hormone. We look at the whole person. This includes their musculoskeletal structure, nervous system integrity, nutritional status, and lifestyle. A patient with poor posture and chronic back pain is in a state of constant physical stress, which will inevitably impact their hormonal health. By addressing these structural issues through chiropractic adjustments, we lower the body’s allostatic load, creating a more favorable environment for hormonal balance. For more on my clinical approach, you can visit my LinkedIn profile.

Navigating Contraception and Hormone Therapy in Perimenopause

One of the most complex clinical scenarios involves women in their 40s who are navigating perimenopause. A frequent question I encounter is about a 45-year-old woman who wants to start testosterone therapy but is also on an oral contraceptive pill (birth control).

This situation requires a careful risk-benefit analysis.

• The Risk of DVT and Stroke: When a 20-year-old takes birth control, the risk of developing a deep vein thrombosis (DVT) is relatively low, and the benefit of preventing pregnancy is high. However, for a 45-year-old woman, the baseline risk for DVT and stroke is already elevated. Adding oral contraceptives, which contain synthetic estrogens, further increases this risk. If she is using it solely for contraception and has other options, the risk-benefit ratio is no longer favorable.
• The SHBG Problem: Oral contraceptives are notorious for dramatically increasing Sex Hormone-Binding Globulin (SHBG). SHBG is a protein that binds to sex hormones, primarily testosterone, rendering them inactive. A woman on birth control could have an SHBG level of 150 or higher. This means that even if we give her testosterone, it will be immediately bound by SHBG, and she won’t feel any of the benefits. Her free testosterone—the active form—will remain incredibly low. These patients are often very difficult to treat and can become frustrated with their lack of progress.
• A Better Strategy:
  1. Find a New Contraceptive: The first step is to explore alternative forms of contraception that do not systemically raise SHBG. An intrauterine device (IUD), particularly a long-acting progestin IUD, is an excellent choice. It provides highly effective local contraception without significantly impacting systemic hormone-binding globulins.
  2. Address the Underlying Issue: If she is taking birth control to manage symptoms like PMS, heavy periods, or endometriosis, we have other, safer tools. Cyclic progesterone, nutritional interventions, and lifestyle changes can effectively manage these symptoms without the cardiovascular risks associated with synthetic estrogens.

By transitioning her off oral contraceptives, her SHBG level will naturally decrease, “freeing up” her testosterone and allowing hormone therapy to be effective. This not only improves her symptoms but also significantly lowers her risk profile for serious adverse events.

Understanding Hormones and Cardiovascular Health

There is a great deal of misinformation surrounding hormone therapy and cardiovascular events. For instance, I’ve been asked if testosterone therapy is linked to conditions like atrial fibrillation (A-Fib). The research points in the opposite direction.

In fact, a pivotal article you can find with a quick search demonstrates that in patients with androgen deficiency, normalizing their testosterone levels before they undergo a cardiac procedure like a cardioversion for A-Fib actually increases the likelihood of the procedure’s success. There is absolutely no established causal link between properly administered testosterone therapy and conditions like A-Fib or erectile dysfunction (ED). These are distinct pathophysiological processes.

Similarly, concerns about testosterone causing an unsafe rise in red blood cell count (hematocrit) are often overstated. As long as the hematocrit level remains in the 40s, there is no increased risk. This is a topic we monitor closely, but it rarely becomes a clinical issue with proper dosing.

The journey to hormonal balance is one of partnership between the patient and the practitioner. It requires a deep understanding of physiology, a commitment to evidence-based medicine, and a holistic perspective that honors the body’s intricate design. By integrating advanced hormonal therapies with foundational practices like chiropractic care, we can empower our patients to achieve not just the absence of disease, but a state of true vitality and wellness.

References

Haddad, R. M., & Riedl, M. (2024). Pharmacokinetics. In StatPearls. StatPearls Publishing.

This reference provides a foundational understanding of the principles of pharmacokinetics, including absorption, distribution, metabolism, and excretion, which are central to dosing and monitoring hormone replacement therapy.

Martin, K. A., & Barbieri, R. L. (2023). Approach to the patient with abnormal uterine bleeding. UpToDate.

This clinical resource details the diagnostic and management strategies for abnormal uterine bleeding, including the use of progesterone to stabilize the endometrium, aligning with the protocols discussed for heavy menstrual bleeding.

de Klerk, N. H., Gu, Y., Geytenbeek, S., & O’Leary, P. (2023). Serum Testosterone, Not Free Testosterone, Is the Marker of Androgen Status in Women. The Journal of Clinical Endocrinology & Metabolism, 108(7), 1694–1702. https://doi.org/10.1210/clinem/dgad011

This research paper discusses the complexities of measuring androgen status in women and the impact of factors like SHBG, which is crucial for understanding why women on oral contraceptives may not respond to testosterone therapy.

Sharma, R., Oni, O. A., Gupta, K., Sharma, M., & Sharma, A. (2021). Testosterone and Atrial Fibrillation: A Review of the Literature. Cureus, 13(9), e17900. https://doi.org/10.7759/cureus.17900